ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Carotid Artery Disease"

  • Abstract Number: 0469 • ACR Convergence 2024

    SCORE2 Is Superior to SCORE in Predicting the Presence of Carotid Plaques and Intima-media Thickness in Rheumatoid Arthritis Patients: A Cross-sectional Study with Carotid Ultrasound

    Cristina Campos Fernández1, Jorge Juan Fragío Gil2, Roxana González Mazario3, Pablo Martínez Calabuig4, Laura Salvador Maicas5, Mireia Lucía Sanmartín Martínez6, Iván Jesús Lorente Betanzos6, Clara Molina Almela6, juan José Lerma Garrido7, Amalia Rueda3 and Jose A Román-Ivorra8, 1Escuela de Doctorado, Universidad Católica de Valencia San Vicente Mártir, Valencia, Spain, 2Hospital General Universitario, Valencia, Comunidad Valenciana, Spain, 3Hospital General de Valencia, Valencia, Comunidad Valenciana, Spain, 4HOSPITAL GENERAL UNIVERSITARIO VALENCIA SPAIN, Ontinyent, Comunidad Valenciana, Spain, 5Consorcio Hospital General Universitario de Valencia, Castellón de la Plana, Comunidad Valenciana, Spain, 6Consorcio Hospital General Universitario de Valencia, Valencia, Comunidad Valenciana, Spain, 7Hospital General Universitario Valencia, Valencia, Comunidad Valenciana, Spain, 8Hospital Universitari i Politècnic la Fe, Valencia, Comunidad Valenciana, Spain

    Background/Purpose: Rheumatoid arthritis (RA) escalates the risk of premature mortality, predominantly through cardiovascular diseases. Although SCORE and its updated version, SCORE2, are employed to assess…
  • Abstract Number: 0497 • ACR Convergence 2024

    Relationship Between the Complement System and Subclinical Carotid Atherosclerosis in Patients with Rheumatoid Arthritis

    Adrián Quevedo-Rodríguez1, Marta Hernández-Díaz2, Dara Rodríguez-González22, Fuensanta Gomez-Bernal3, Juan Carlos Quevedo-Abeledo4, Agustín F González-Rivero2, Elena González López5, gonzalo Ocejo-Viñals5, Miguel Angel Gonzalez-Gay6 and ivan Ferraz-Amaro7, 1Hospital de Gran Canaria Doctor Negrin, Las Palmas de Gran Canaria, Spain, 2Hospital Universitario de Canarias, SANTA CRUZ DE TENERIFE, Spain, 3Hospital Universitario de Canarias, Santa Cruz de Tenerife, Canarias, Spain, 4Hospital Universitario de Gran Canaria Dr Negrín, Las Palmas de GC, Canarias, Spain, 5Department of Immunology, Marqués de Valdecilla University Hospital (HUMV), Santander, Spain, 6University of Cantabria, Fundación Jimenez Díaz, Madrid, Madrid, Spain, 7Rheumatology, Hospital Universitario de Canarias, Santa Cruz de Tenerife, Canarias, Spain

    Background/Purpose: Patients with rheumatoid arthritis (RA) have an increased risk of cardiovascular (CV) events and CV mortality. Carotid subclinical atherosclerosis is independently associated with incident…
  • Abstract Number: 0611 • ACR Convergence 2024

    Subclinical Atherosclerosis Is Associated with Future Cardiovascular Events in Systemic Lupus Erythematosus Patients at Apparent Low Risk for Cardiovascular Disease: A Longitudinal Prospective Study

    Arthur Mageau1, Marie-Paule Chauveheid2, Chrystelle Francois2, Thomas Papo1 and Karim Sacré1, 1Université Paris Cité, Paris, France, 2Assistance Publique Hôpitaux de Paris, Paris, France

    Background/Purpose: Cardiovascular events (CVE) are the leading cause of mortality for patients living with systemic lupus erythematosus (SLE). Besides the traditional cardiovascular risk factors, the…
  • Abstract Number: 1359 • ACR Convergence 2024

    Association of Coronary Artery Calcium Score and Growth Differentiation Factor 15 in Rheumatoid Arthritis

    Jessica Roldan Ortega1, Francisco Castillo-Castellon2, Evelyn Aranda Cano3, Luz Angelica Viruel-Mejia4, Itzel Palafox Sosa5, David Vera Bustamante6, Fausto Sánchez Muñoz2, ⁠Yaneli Juárez-Vicuña7, Luis H. Silveira Torre8 and Laura Aline Martinez-Martinez9, 1Instituto Nacional de Cardiología Ignacio Chávez, Ciudad de México, Mexico, 2Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico, 3Instituto Nacional de Cardiología Ignacio Chávez, Ciudad de Mexico, Mexico, 4Rheumatology Departement at National Institute of Cardiology Ignacio Chavez - Universidad Autonoma del Estado de Hidalgo, Tula de Allende, Hidalgo, Mexico, 5Escuela Superior de Medicina-Instituto Politecnico Nacional, Ciudad de México, Mexico, 6Benemerita Universidad Autonoma de Puebla, Heroica Puebla de Zaragoza, Puebla, Mexico, 7Instituto Nacional de Cardiología Ignacio Chávez, Departamento de Inmunología, Investigador en Ciencias Médicas C, Mexico City, Mexico, 8Department of Rheumatology , Instituto Nacional de Cardiología Ignacio Chávez., Mexico City, Mexico, 9Rheumatology Department - National Institute of Cardiology Ignacio Chavez, Mexico City, Distrito Federal, Mexico

    Background/Purpose: Cardiovascular diseases are the leading cause of death in RA patients [Gravallese EM, Firestein GS. N Engl J Med. 2023;388:529-42]. However, risk calculation has…
  • Abstract Number: 1440 • ACR Convergence 2024

    Significant Indicators Identified for Carotid Doppler Ultrasound Use in Axial Spondyloarthritis Patients Without Conventional Cardiovascular Risk Factors

    Brona Dinneen1 and Finbar O'Shea2, 1St James's Hospital,, Dublin, Dublin, Ireland, 2St James's Hospital, Dublin, Dublin, Ireland

    Background/Purpose: The EULAR  cardiovascular screening recommendations advocate for the use of carotid dopplers in patients with inflammatory joint diseases to detect subclinical atherosclerosis. Despite these…
  • Abstract Number: 1557 • ACR Convergence 2024

    Estimation of Cardiovascular Risk in Patients with Systemic Sclerosis – Accuracy of Tools Based on SCORE and Its Modifications Compared to Ultrasound Examination of Subclinical Atherosclerosis

    Sabína Oreská1, Aneta Prokopcová2, Hana Storkanova1, Jaroslav Kudlicka3, Vladimir Tuka4, Ondrej Mikes4, Zdislava Krupickova4, Martin Satny4, Eva Chytilova4, Jan Kvasnicka4, Maja Spiritovic5, Barbora Hermankova6, Petr Cesak7, Marian Rybar8, Karel Pavelka9, Ladislav Šenolt2, Radim Becvar1, Jiří Vencovský2, Michal Vrablik4 and Michal Tomcik1, 1Institute of Rheumatology and Department of Rheumatology, First Faculty of Medicine, Charles University, Prague, Czech Republic, Prague, Czech Republic, 2Institute of Rheumatology and Department of Rheumatology, First Faculty of Medicine, Charles University, Prague, Czech Republic, 3Institute of Rheumatology, Prague, Czech Republic, Department of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic, Prague, Czech Republic, 43rd Department of Internal Medicine, General University Hospital and 1st Faculty of Medicine, Charles University, Prague, Czech Republic, Prague, 5Institute of Rheumatology, Prague, Czech Republic, Prague, 6Institute of Rheumatology, Prague, Czech Republic, Prague, Czech Republic, 7Department of Human Movement Laboratory, Faculty of Physical Education and Sport, Charles University, Prague, Czech Republic, Prague, 8Department of Biomedical Technology, Faculty of Biomedical Engineering, Czech Technical University in Prague, Kladno, Czech Republic, Kladno, 9Institute of Rheumatology and Charles University, Praha, Czech Republic

    Background/Purpose: Patients with systemic sclerosis (SSc) have increased cardiovascular (CV) risk due to accelerated atherosclerosis (ATS) caused by systemic inflammation, and vascular impairment. To date,…
  • Abstract Number: 2221 • ACR Convergence 2024

    Association Between Serum Uric Acid/Serum Creatinine Index and Carotid Plaque in Patients with Rheumatoid Arthritis

    Andrea Guajardo Aldaco1, Dionicio Galarza-Delgado2, Iris Jazmín Colunga Pedraza1, jose Ramon Azpiri-Lopez3, Jesus Cardenas-de la Garza4, Rosa Icela Arvizu-Rivera1, Maria F. Elizondo-Benitez5, Valeria Gonzalez-Gonzalez6 and Diego Salcedo-Almanza7, 1Division of Rheumatology, University Hospital "Dr. Jose Eleuterio Gonzalez", Universidad Autonoma de Nuevo Leon, Monterrey, Mexico, 2UANL Hospital Universitario, Monterrey, Nuevo León, Mexico, 3Division of Cardiology, University Hospital "Dr. Jose Eleuterio Gonzalez", Universidad Autonoma de Nuevo Leon, Monterrey, Mexico, 4Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, Mexico, 5Division of Rheumatology, University Hospital "Dr. Jose Eleuterio Gonzalez", Universidad Autonoma de Nuevo Leon, Monterrey, Nuevo León, Mexico, 6Division of Rheumatology, University Hospital "Dr. Jose Eleuterio Gonzalez", Universidad Autonoma de Nuevo Leon, Monterrey, Nuevo León, Mexico, 7Division of Radiology, University Hospital "Dr. Jose Eleuterio Gonzalez", Universidad Autonoma de Nuevo Leon, Monterrey, Nuevo León, Mexico

    Background/Purpose: Rheumatoid arthritis (RA) is a chronic, systemic autoimmune disease. The serum uric acid/serum creatinine ratio (SUA/SCr), which represents uric acid levels in the blood…
  • Abstract Number: 2235 • ACR Convergence 2024

    The Updated PREVENT (Predicting Risk of CVD EVENTs) Algorithm Is Not Able to Indicate Subclinical Coronary or Carotid Atherosclerosis Better Than the Traditional Pooled Cohort Equations in Rheumatoid Arthritis

    J. Alex B. Gibbons1, Joan Bathon2 and Jon Giles3, 1Columbia University Vagelos College of Physicians & Surgeons, New York, NY, 2Columbia University, NEW YORK, NY, 3Cedars Sinai Medical Center, Los Angeles, CA

    Background/Purpose: Patients with RA are at increased risk of atherosclerotic cardiovascular disease (ASCVD), yet traditional 10-year CVD risk calculators—such as the 2013 Pooled Cohort Equations…
  • Abstract Number: 1469 • ACR Convergence 2023

    Prevalence of Cardiovascular Disease in a Populations Based Registry of Patients with Systemic Lupus Erythematosus

    Daniel Joyce1, Jeffrey. Berger2, Allison Guttmann3, Ghadeer Hasan4, Jill Buyon5, H Michael Belmont1, Jane Salmon6, Anca Askanase7, Joan Bathon8, Laura Geraldino-Pardilla9, Yousaf Ali10, Ellen Ginzler11, Chaim Putterman12, Caroline Gordon13, Charles Helmick14, Kamil Barbour15, Heather Gold16, Hilary Parton17 and Peter Izmirly2, 1NYU School of Medicine, New York, NY, 2New York University School of Medicine, New York, NY, 3Atlantic Health System, Summit, NJ, 4Optum, Jersey City, NJ, 5NYU Grossman School of Medicine, New York, NY, 6Hospital for Special Surgery, New York, NY, 7Columbia University Medical Center, New York, NY, 8Columbia University, New York, NY, 9Division of Rheumatology, Columbia University Irving Medical Center, New York, NY, 10Icahn School of Medicine at Mount Sinai, New York, NY, 11SUNY Downstate Health Sciences University, Brooklyn, NY, 12Albert Einstein College of Medicine, Bronx, NY, 13Institute of Inflammation and Ageing, University of Birmingham, Birmingham, United Kingdom, 14NA, Atlanta, GA, 15Centers for Disease Control and Prevention, Atlanta, GA, 16New York University, New York, NY, 17New York City Department of Health and Mental Hygiene, Queens, NY

    Background/Purpose: Patients with SLE are at increased risk for cardiovascular disease (CVD). Population estimates of CVD in SLE remains limited for non-White racial/ethnic populations in…
  • Abstract Number: 0580 • ACR Convergence 2023

    Performance of Conventional Cardiovascular Risk Scores in Identifying Subclinical Atherosclerosis in Systemic Lupus Erythematosus

    Gayathri MS, Aishwarya Gopal, Molly Mary Thabah, Christina Mariaselvam, jaiveer Singh and Chengappa Kavadichanda, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India

    Background/Purpose: Cardiovascular disease (CVD) is a major cause of mortality in systemic lupus erythematosus (SLE). Role of conventional risk scores which predict cardiovascular events, to…
  • Abstract Number: 1114 • ACR Convergence 2023

    Role of Dual-energy Computed Tomography (DECT) in Detection of Carotid Artery Monosodium Urate Deposition in Patients with Gout

    Muhammad Danish Sarfraz, Lee Treanor, Savvas Nicolaou and Adnan Sheikh, University of British Columbia, Vancouver, BC, Canada

    Background/Purpose: To find out if a Dual energy CT can detect monosodium urate deposition in carotid arteries and whether the presence of monosodium urate crystals…
  • Abstract Number: 1283 • ACR Convergence 2023

    Atherogenic Index of Plasma Identifies Patients with Rheumatoid Arthritis and Increased Carotid Intima-Media Thickness

    Dionicio A. Galarza-Delgado1, Iris Colunga1, José Ramón Azpiri-López1, Valeria Gonzalez-Gonzalez2, Victor Beltran3, Angel Arias Peralta4, Jesus Alberto Cardenas-De la Garza5 and Rosa Arvizu-Rivera6, 1Hospital Universitario UANL, Monterrey, Mexico, 2Universidad Autónoma de Nuevo León, Monterrey, Mexico, 3Rheumatology Service Hospital Universitario "Dr. José Eleuterio González", Monterrey, Mexico, 4Medicine Faculty, Universidad Autonoma De Nuevo Leon, Monterrey, Mexico, 5Hospital Universitario "Dr. José Eleuterio González", San Nicolas, Mexico, 6Hospital Universitario "Dr. José Eleuterio Gonzalez", Escobedo, Mexico

    Background/Purpose: The atherogenic index of plasma (AIP) is a novel marker to identify cardiovascular disease. Recently, AIP was reported to be related to long-term cardiovascular…
  • Abstract Number: 002 • 2023 Pediatric Rheumatology Symposium

    Re-analysis of the APPLE (Atherosclerosis Prevention in Paediatric Lupus Erythematosus) Trial Identifies Novel Determinants of Patient Heterogeneity and a Distinct Lipid Metabolomic Signature of Atherosclerosis Progression

    Coziana Ciurtin1, Junjie Peng1, Pierre Donnes1, Stacy Ardoin2, Laura Schanberg3, Laura Lewandowski4, George A Robinson1 and Elizabeth Jury1, 1University College London, London, United Kingdom, 2Nationwide Children's Hospital, Columbus, OH, 3Duke University Medical Center, Durham, NC, 4NIAMS, NIH, Bethesda, MD

    Background/Purpose: Juvenile-onset systemic lupus erythematosus (JSLE) is associated with chronic inflammation and increased risk of atherosclerosis. The APPLE trial was a randomised, placebo-controlled trial of…
  • Abstract Number: 061 • 2023 Pediatric Rheumatology Symposium

    Variation in Treatment Approaches to IVIG- Refractory Kawasaki Disease (KD) Among Pediatric Rheumatologists: The Childhood Arthritis and Rheumatology Research Alliance (CARRA) Treatment of Refractory KD Survey

    Daniel Ibanez1, Bianca Lang2, Ali Yalcindag3, Linda Wagner-Weiner4, Julia Shalen5, Kenneth Schikler6, Shoghik Akoghlanian7, Hulya Bukulmez8, Kristen Hayward9, Sivia Lapidus10, Andrea Ramirez11, Robert Sundel1, Cagri Yildirim-Toruner12 and CARRA Registry Investigators13, 1Boston Children's Hospital, Boston, MA, 2Dalhousie University - Halifax, Halifax, NS, Canada, 3Hasbro Children's Hospital, Milton, MA, 4The University of Chicago, Chicago, IL, 5Johns Hopkins University, Baltimore, MD, 6University of Louisville School of Medicine Norton Children's Hospital, Louisville, KY, 7Nationwide Children's Hospital, Columbus, OH, 8MetroHealth Medical Center, Case Western Reserve, Cleveland, OH, 9Seattle Children's Hospital/University of Washington School of Medicine, Seattle, WA, 10Department of Pediatrics, Joseph M. Sanzari Children's Hospital, Hackensack University Medical Center, Hackensack, NJ, 11Baylor College of Medicine, Houston, TX, 12Baylor College of Medicine, Texas Children's Hospital, Houston, TX, 13CARRA, Washington, DC

    Background/Purpose: Kawasaki disease (KD) is the leading cause of acquired heart disease in children in North America. Initial treatment with IVIG has significantly reduced the…
  • Abstract Number: 0317 • ACR Convergence 2022

    Full Characterization of the Three Pathways of Complement System in Patients with Systemic Lupus Erythematosus: Relation to Disease Expression

    Ivan Ferraz Amaro1, maría García-González2, carmen Ferrer-Moure2, Fuensanta Gómez-Bernal2, Antonia De Vera-González2, Alejandra González Delgado2, Agustín Francisco González-Rivero2, Yolanda Fernández-Cladera2, Juan Carlos Quevedo Abeledo3 and Federico Díaz-González4, 1Division of Rheumatology. Hospital Universitario de Canarias. Spain., Santa Cruz de Tenerife, Spain, 2Hospital Universitario de Canarias, Santa Cruz de Tenerife, Spain, 3Hospital Universitario Dr. Negrín, Santa Cruz de Tenerife, Spain, 4Hospital Universitario de Canarias, Santa Cruz de Tenerife

    Background/Purpose: Activation of the classical complement (C) pathway by immune complexes is a characteristic of patients with systemic lupus erythematosus (SLE). Accelerated consumption outstrips synthesis…
  • 1
  • 2
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology